← Evidence map

ArticleNeuro-oncology practice2022

First-line chemotherapeutic treatment for oligodendroglioma, WHO grade 3-PCV or temozolomide?

Matthijs van der Meulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35601972